Sentynl Therapeutics, Inc
- Biotech or pharma, therapeutic R&D
Sentynl is a global commercial-stage rare disease company focused on in-licensing late-stage programs and revenue stage products. Our current therapies treat disorders in neurology, genetics and inborn errors of metabolism.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}